Skip to main content
. 2021 Jan 29;115:e200520. doi: 10.1590/0074-02760200520

TABLE I. Drug resistance profile according to whole-genome sequencing tools for first-line anti-tuberculosis.

Genomic tools Multidrug resistant Other resistance Susceptible
TB-profiler 18 (25.4%) 14 (19.7%) 39 (54.9%)
PhyResSea 1 (1.4%) 25 (36.2%) 43 (62.4%)
KvarQ 18 (25.4%) 13 (18.3%) 40 (56.3%)
CASTBb 15 (25%) 34 (56.7%) 11 (18.3%)
RSniffer 0 0 71 (100%)
Mykrobe 18 (25.4%) 17 (23.9%) 36 (50.7%)
MTBSEQ 17 (23.9%) 23 (32.4%) 31 (43.7%)

a: n = 69; b: n = 60.